Ketamine G.L. Pharma (Ketamine)

Ketamine works by blocking NMDA receptors in the brain, which reduces excitatory neurotransmission. This antagonism creates a dissociative state, produces strong analgesia, and can modulate mood pathways, contributing to its use in anesthesia and certain depressive conditions.

The dose of Ketamine G.L. Pharma is determined by the prescribing clinician based on the specific indication, patient characteristics, and procedural requirements. Only a qualified healthcare professional should set the appropriate dosing regimen.

Safety data for ketamine use during pregnancy or while breastfeeding are limited. It is generally advised to avoid use unless the potential benefits outweigh the potential risks, and decisions should be made by a qualified obstetric or pediatric specialist.

To order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and necessary import documentation.

Ketamine differs from agents such as propofol or volatile anesthetics by providing dissociative anesthesia and preserving airway reflexes, while also producing analgesia and cardiovascular stimulation. Its unique profile makes it valuable in trauma, emergency settings, and when hemodynamic stability is desired.

Ketamine G.L. Pharma should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the product from excessive light, moisture and physical damage. Follow standard aseptic handling procedures for injectable medicines.

Ketamine G.L. Pharma is administered intravenously by a qualified healthcare professional. The drug is supplied as an injectable solution and is given as a bolus or continuous infusion, depending on the clinical situation and the prescriber's instructions.

The most serious risks include respiratory depression requiring airway support, severe hypertension or cardiac arrhythmias, and emergence reactions such as vivid dreams, agitation or psychotic-like experiences. Prompt monitoring and supportive care are essential to manage these events.

Ketamine G.L. Pharma should be avoided in patients with known hypersensitivity to ketamine, uncontrolled hypertension, severe cardiovascular disease, active psychosis, or those for whom a dissociative anesthetic is contraindicated. Clinical judgment is required to assess suitability.